Loading Episode...
The Drug Science Podcast - Fascinate Productions EPISODE 22, 4th August 2020
22. Medical Psychedelics Working Group Q&A with Professor Jo Neill
00:00:00 00:49:24

22. Medical Psychedelics Working Group Q&A with Professor Jo Neill

On July 14th 2020, the UK’s leading independent scientific body on drugs has launched the Drug Science Medical Psychedelics Working Group. Building off the success of the Medical Cannabis Working Group, the Medical Psychedelics Working Group is a consortium of Drug Science experts, leading academics, researchers and policy specialists, supported by industry partners. The group’s aim is to create a rational and enlightened approach to psychedelic research and clinical treatment. The group will explore innovation within the psychedelic space with a specific focus on how psychedelics can be integrated into primary and secondary healthcare. Evidence-based science, sharing data, and strong partnerships are keys to success for the psychedelic community. The purpose of this group is to break down the barriers of 50 years of medical censorship by creating a rational and enlightened approach to psychedelic research and clinical treatment, ensuring the UK is a world leader in psychedelic medicine.

Jo Neill is Professor of Psychopharmacology at the University of Manchester (Division of Pharmacy & Optometry). She is Chair of the Medical Psychedelics Working Group for Drug Science and a committee member, a scientific advisor for Heroic Hearts UK and the Conservative Drug Policy Reform Group. She is co-founder of b-neuro, a University based Contract Research Organisation developing new treatments for mental illness through animal models. Jo is past President of the British Association for Psychopharmacology (President 2016-2018). She served on the Research Excellence Framework panel for Unit of Assessment 3 (Allied Health Professions, Dentistry, Nursing and Pharmacy) in 2014. Jo is working with Policy at Manchester to educate the public about the urgent need for drug law reform and suspension of Schedule 1 restrictions to enable research into the medicinal properties of currently illegal drugs.

Medical Psychedelics Working Group

B-Neuro

Neil Woods episode

Psilocybin for depression episode

Veterans and psychedelics part 1

Veterans and psychedelics part 2

Veterans and psychedelics part 3

Psilocybin slides

MDMA slides

Judith Aldridge

Fiona Measham

James Morgan

DMT episode

Neil Woods MP letter

Denver decriminalisation

Oakland decriminalisation

Psilocybin in The Telegraph

Magic Medicine Film

US Expanded Access Programme

From Shock to Awe

Anorexia trial at Imperial College

Become a Drug Science Community Member: https://www.donate.drugscience.org.uk/

Twitter: @ProfDavidNutt @Drug_Science

A Fascinate Productions podcast for Drug Science